|
Federal Register
Notices > Importers Notice of Application 2009
> AllTech Associates Inc.
FR Doc E9-14727[Federal Register: June 24, 2009 (Volume 74, Number 120)]
[Notices] [Page 30111] From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr24jn09-124]
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Importer of Controlled Substances; Notice of Application
Pursuant to 21
U.S.C. 958(i), the Attorney General shall, prior to issuing a
registration under this Section to a bulk manufacturer of a controlled substance
in schedule I or II and prior to issuing a regulation under 21
U.S.C. 952(a)(2)
authorizing the importation of such a substance, provide manufacturers holding
registrations for the bulk manufacture of the substance an opportunity for a
hearing.
Therefore, in accordance with 21 CFR
1301.34(a), this is notice that on April
21, 2009, AllTech Associates Inc., 2051 Waukegan Road, Deerfield, Illinois
60015, made application to the Drug Enforcement Administration (DEA) to be
registered as an importer of the basic classes of controlled substances listed
in schedules I and II:
| Drug |
Schedule |
| Gamma Hydroxybutyric Acid (2010) |
I |
| Heroin (9200) |
I |
| Cocaine (9041) |
II |
| Codeine (9050) |
II |
| Hydrocodone (9193) |
II |
| Meperidine (9230) |
II |
| Methadone (9250) |
II |
| Morphine (9300) |
II |
The company plans to import these controlled substances for the manufacture
of reference standards.
Any manufacturer who is presently, or is applying to be, registered with DEA
to manufacture such basic classes of controlled substances may file comments or
objections to the issuance of the proposed registration and may, at the same
time, file a written request for a hearing on such application pursuant to 21
CFR 1301.43 and in such form as prescribed by 21 CFR
1316.47.
Any such written comments or objections should be addressed, in quintuplicate,
to Drug Enforcement Administration, Office of Diversion Control, Federal
Register Representative (ODL), 8701 Morrissette Drive, Springfield, VA 22152 and
must be filed no later than July 24, 2009.
This procedure is to be conducted simultaneously with, and independent of,
the procedures described in 21 CFR 1301.34(b), (c), (d), (e), and (f). As noted
in a previous notice published in the Federal Register on September 23, 1975,
(40 FR 43745-46), all applicants for registration to import a basic class of any
controlled substances in Schedule I or II are and will continue to be required
to demonstrate to the Deputy Assistant Administrator, Office of Diversion
Control, Drug Enforcement Administration, that the requirements for such
registration pursuant to 21
U.S.C. 958(a), 21
U.S.C. 823(a), and 21 CFR
1301.34(b), (c), (d), (e), and (f) are satisfied.
Dated: June 15, 2009.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug
Enforcement Administration.
[FR Doc. E9-14727 Filed 6-23-09; 8:45 am]
BILLING CODE 4410-09-P
NOTICE: This is an
unofficial version. An official version of these publications may be obtained
directly from the Government Printing Office (GPO).
|